Rock Springs Capital Management’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-341,637
Closed -$6.95M 122
2023
Q2
$6.95M Sell
341,637
-234,963
-41% -$4.76M 0.17% 84
2023
Q1
$12.5M Hold
576,600
0.3% 71
2022
Q4
$17.9M Hold
576,600
0.43% 62
2022
Q3
$14.7M Buy
576,600
+4,300
+0.8% +$101K 0.38% 65
2022
Q2
$11.6M Buy
572,300
+9,000
+2% +$199K 0.34% 72
2022
Q1
$13.9M Buy
563,300
+24,600
+5% +$745K 0.35% 74
2021
Q4
$18.7M Buy
538,700
+2,868
+0.5% +$91K 0.43% 69
2021
Q3
$14.5M Buy
535,832
+600
+0.1% +$15.2K 0.31% 85
2021
Q2
$13.9M Hold
535,232
0.27% 97
2021
Q1
$11.5M Buy
535,232
+225,819
+73% +$5.7M 0.25% 102
2020
Q4
$6.65M Buy
309,413
+300
+0.1% +$7.29K 0.14% 132
2020
Q3
$4.56M Buy
309,113
+2,400
+0.8% +$43.3K 0.12% 132
2020
Q2
$6.85M Buy
306,713
+6,713
+2% +$123K 0.19% 118
2020
Q1
$4.24M Buy
300,000
+165,000
+122% +$2.5M 0.18% 107
2019
Q4
$2.19M Sell
135,000
-105,000
-44% -$2.48M 0.07% 117
2019
Q3
$8.4M Buy
240,000
+21,500
+10% +$1.02M 0.33% 82
2019
Q2
$12.3M Buy
218,500
+48,500
+29% +$3.49M 0.45% 76
2019
Q1
$12.4M Buy
170,000
+34,000
+25% +$2.35M 0.48% 71
2018
Q4
$8.68M Sell
136,000
-29,000
-18% -$2.16M 0.41% 76
2018
Q3
$16.5M Buy
165,000
+15,000
+10% +$1.24M 0.6% 60
2018
Q2
$10.7M Buy
150,000
+15,000
+11% +$1.26M 0.41% 81
2018
Q1
$14.1M Sell
135,000
-7,400
-5% -$834K 0.6% 64
2017
Q4
$14.3M Sell
142,400
-7,600
-5% -$559K 0.65% 58
2017
Q3
$5.24M Buy
+150,000
New +$4.05M 0.24% 102

Other funds holding ANAB

Rock Springs Capital Management's ANAB Position: Q3 2023 in Review

Rock Springs Capital Management sold out of AnaptysBio (ANAB) in Q3 2023, closing a stake of 341,637 shares — an estimated $6.95M sold.

Rock Springs Capital Management first reported a position in ANAB in Q3 2017 and held it in 24 quarters. The position peaked at $18.7M in Q4 2021. 116 funds tracked by Wall St. Rank hold ANAB as of Q3 2023.

  • Rock Springs Capital Management reported no remaining AnaptysBio position as of Q3 2023 after selling out during the quarter.
  • Rock Springs Capital Management sold 341,637 AnaptysBio shares in Q3 2023, an estimated $6.95M.
  • Rock Springs Capital Management first reported a position in AnaptysBio in Q3 2017 and held it in 24 quarters.
  • Rock Springs Capital Management's AnaptysBio position peaked at $18.7M in Q4 2021.
  • 116 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2023.

Based on Rock Springs Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.